Cognition Therapeutics, Inc.

US$0.69As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CGTXHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (43.51%)
Div yield —
ROE (48.60%)
Biotechnology
Beta (5Y) 1.80
PE TTM —
TSR TTM (61.62%)
Mkt cap US$65.33M
ROIC (70.50%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.776
12.99%
(27.25%)
Hold 6|6|1|8|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
15.92%
15.98%
14.80%
10.85%
Revenue$M
3.901
4.087
4.202
4.191
(5.11%)
2.33%
6.48%
8.42%
Peers (US$65.33M)
Cap (US$)
PE
67.46M
—
Capital
TTM
5Y
10Y
Leveragex
1.258
0.957
0.888
EBIT/Intx
8.159
0.425
0.417
Own earn%
60.95
(59.88)
(59.98)
Sh yield%
30.81
34.50
36.30
Owners
Insiders/Inst%
4.10
43.11
Short interest%
5.53
SBC / revenue%
4.67
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
11–16
$1 testx
—
Incr. ROIC%
24